Amerise Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 24, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	55	44	46	90	109	54	Upgrade
Market Cap Growth	72.86%	-5.71%	-48.53%	-17.58%	101.22%	-4.65%	Upgrade
Enterprise Value	55	45	46	90	121	54	Upgrade
Last Close Price	0.84	0.66	0.70	1.36	1.65	0.82	Upgrade
PE Ratio	-	-	-	16.36	-	-	Upgrade
PS Ratio	155.02	121.46	525.55	0.94	-64.52	9464.81	Upgrade
PB Ratio	1.05	0.81	0.84	1.59	2.14	1.00	Upgrade
P/TBV Ratio	1.05	0.81	0.84	1.59	2.14	1.00	Upgrade
P/OCF Ratio	-	-	-	146.34	-	1.11	Upgrade
EV/Sales Ratio	154.58	124.09	524.95	0.94	-	9481.41	Upgrade
EV/EBIT Ratio	-	-	-	16.32	-	-	Upgrade
Debt / Equity Ratio	-	-	0.02	0.02	-	-	Upgrade
Asset Turnover	-	0.01	0.00	1.09	-	0	Upgrade
Quick Ratio	-	1.36	0.37	0.99	0.04	0.04	Upgrade
Current Ratio	-	1.48	0.37	0.99	0.04	0.04	Upgrade
Return on Equity (ROE)	-	-2.68%	-2.13%	10.24%	-6.41%	-2.71%	Upgrade
Return on Assets (ROA)	-	-1.65%	-1.18%	3.90%	-3.62%	-1.59%	Upgrade
Return on Capital (ROIC)	-0.90%	-1.66%	-1.83%	6.35%	-4.01%	-1.68%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	9.60%	-	-	Upgrade
Earnings Yield	-1.42%	-3.35%	-2.57%	6.11%	-3.09%	-2.75%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.